Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Syndax Pharmaceuticals (SNDX) Debt Ratio (2020 - 2024)

Syndax Pharmaceuticals (SNDX) has 5 years of Debt Ratio data on record, last reported at 0.47 in Q4 2024.

  • For Q4 2024, Debt Ratio changed N/A year-over-year to 0.47; the TTM value through Dec 2024 reached 0.47, changed N/A, while the annual FY2024 figure was 0.47, N/A changed from the prior year.
  • Debt Ratio reached 0.47 in Q4 2024 per SNDX's latest filing, up from 0.05 in the prior quarter.
  • Across five years, Debt Ratio topped out at 0.47 in Q4 2024 and bottomed at 0.04 in Q4 2021.
  • Average Debt Ratio over 4 years is 0.12, with a median of 0.08 recorded in 2021.
  • The widest YoY moves for Debt Ratio: up 23.37% in 2021, down 61.56% in 2021.
  • A 4-year view of Debt Ratio shows it stood at 0.07 in 2020, then plummeted by 33.27% to 0.04 in 2021, then grew by 11.32% to 0.05 in 2022, then surged by 853.76% to 0.47 in 2024.
  • Per Business Quant database, its latest 3 readings for Debt Ratio were 0.47 in Q4 2024, 0.05 in Q2 2022, and 0.05 in Q1 2022.